Kappac Pharma Ltd.

BSE: 506938

₹112.85

up-down-arrow-5.90 (-4.97%)

As on 06-Jan-2015IST

Market cap

info icon

₹341 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

9

Div. Yield

info icon

0 %

Kappac Pharma Share Price

Compare

High: Low: Return:

Max: Min:

Max: Min:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 112.85 High: 112.85

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹-2 Cr

  • ROEROE information

    -0.3 %

  • ROCEROCE information

    -0.3 %

  • Industry P/EIndustry P/E information

    39.9

  • EV/EBITDAEV/EBITDA information

    -155.6

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹-0.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    30,258,600

10 Years Aggregate

CFO

₹-18.74 Cr

EBITDA

₹-2.05 Cr

Net Profit

₹-1.46 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Kappac Pharma
-19.1 -56.7 -68.4 -82.8 -- -- 15.6
BSE Sensex*
-9.3 -1.4 2.7 -3.8 5.7 6.2 10.5
BSE Healthcare#
18.0 1.1 9.5 17.5 22.5 14.3 12.2
As on 06-Jan-2015  |  *As on 31-Aug-2026  |  #As on 31-Aug-2026
Company
2014
Kappac Pharma
-78.0
BSE Sensex
29.9
BSE Healthcare
47.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Kappac Pharma
112.9 341.5 0.0 -2.2 -- -6.2 -- 9.0
3,277.2 26,870.9 1,461.8 387.4 34.5 25.2 69.6 15.5
817.4 16,000.2 7,784.0 688.5 10.6 14 23.1 2.7
449.8 17,241.8 2,141.5 58.5 5.8 3.3 162.3 4.5
826.0 20,739.4 5,632.3 662.4 17.2 14.3 31.3 4.2
1,518.1 17,579.4 1,543.3 -48.6 3.6 -0.6 -- 3.0
213.9 29,103.3 9,205.3 -371.8 1.7 -3.8 -- 3.6
1,816.8 29,891.8 1,935.8 288.2 20.6 29.8 103.7 22.3
402.3 16,284.0 3,600.2 221.0 9.7 5.6 73.7 3.4
1,900.2 32,103.6 3,564.0 414.0 15.3 8.4 78.5 6.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Kappac Pharma

Manufacture of allopathic pharmaceutical preparations

  • Incorporated

    1981

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Mumbai, Maharashtra

  • Website

    --

FAQs for Kappac Pharma

The share price of Kappac Pharma Ltd is ₹112.85 (BSE) as of 06-Jan-2015 IST. Kappac Pharma Ltd has given a return of -82.77% in the last 1 years.

Since, TTM earnings of Kappac Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Kappac Pharma Ltd is 8.97 times as on 06-Jan-2015, a 112 premium to its peers’ median range of 4.23 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2014
0.00
54.69
2013
0.00
5.61
2012
0.00
1.65
2011
0.00
3.32
2010
0.00
3.57

The 52-week high and low of Kappac Pharma Ltd are Rs -- and Rs -- as of 31-Aug-2026.

Kappac Pharma Ltd has a market capitalisation of ₹ 341 Cr as on 06-Jan-2015. As per SEBI classification, it is a company.

Before investing in Kappac Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...